Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02085460 |
|---|---|
| Brief Title: | A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer |
| First Submitted : | March 11, 2014 |
| First Submitted that Met QC Criteria : | March 11, 2014 |
| First Posted : | March 12, 2014 (Estimate) |
| Results First Submitted : | March 11, 2021 |
| Results First Submitted that Met QC Criteria : | March 11, 2021 |
| Results First Posted : | April 6, 2021 |
| Last Update Submitted that Met QC Criteria : | September 22, 2021 |
| Last Update Posted : | October 18, 2021 |